| |
 
Q.E.P.D.
La Facultad de Ciencias de la Salud, comparte la pena de la Familia Kuthy, por el sensible fallecimiento del
Dr. Don José Kuthy Porter
Quien fuera Director de Nuestra Facultad, siendo un pilar importante en la fundación de la hoy Facultad de Bioética de la cual hasta el día de ayer fue Director emérito.
Atentamente,
Dr. Tomás Barrientos Fortes y coordinadores de la Facultad de Ciencias de la Salud
Inicio de Semestre:
Estimados alumnos regresamos pronto de vacaciones, el semestre Agosto Noviembre 2010 está por iniciar es muy importante de que te cerciores de lo siguiente antes de hacer tus horarios:
Terminado esto podrás hacer tus horarios de manera conveniente, mayores informes acude a la coordinación de tu licenciatura:
- Médico Cirujano: Dr. José Antonio Ruy-Díaz Reynoso. Ext. 7213 jaruy@anahuac.mx
- Nutrición: Lic. Magdalena Urrutia Sanvicente. Ext. 7206 magdalena.urrutia@anahuac.mx
- Cirujano Dentista: Dr. Carlos Robles Bonilla Ext.7273
crobles@anahuac.mx
Long-Term Metformin Use Associated With Vitamin B-12 Deficiency.
HealthDay (5/21, Dotinga) reported that, according to a study published May 20 in the British Medical Journal, "diabetics who take the drug metformin over the long term should get their vitamin B-12 levels checked regularly to see if they are developing a vitamin deficiency." For the study, researchers observed "the effects of metformin treatment on 390 patients with type 2 diabetes" who were "prescribed either the drug (196 patients) or a placebo (194 patients) to be taken three times a day for more than four years."
After "4.3 years of treatment...the hazard ratio for developing vitamin B12 deficiency while on metformin was 5.5 relative to placebo," MedPage Today (5/21, Gever) reported. Moreover, the "'decrease is not a transitory phenomenon, but persists and grows over time,' the researchers wrote."
MedWire (5/21, Albert) reported that in order to prevent a vitamin B-12 deficiency, the study's authors suggested that "regular measurement of vitamin B-12 concentrations during long term metformin treatment should be strongly considered."
High-Dose Vitamin B Therapy May Be Dangerous For Diabetes Patients With Kidney Disease.
HealthDay (4/27, Preidt) reported, "High-dose vitamin B therapy is dangerous for diabetics with kidney disease, and patients on this regimen should stop immediately," according to a paper in the Journal of the American Medical Association. When researchers in Canada "began the study, they believed it would show that high-dose vitamin B therapy (folic acid, vitamin B6 and vitamin B12) would improve patients' kidney function and reduce their risk of heart attack and stroke." But they eventually discovered that "patients on high-dose vitamin B therapy had significant worsening of kidney function, and twice as many heart and stroke incidents as patients taking a placebo."
"Although it's unclear why B vitamins seem linked to increased health risks," the UK's Globe and Mail (4/27, Weeks) reported that lead study author David Spence "said it may be because they are normally excreted in urine. Patients with kidney disease may not be able to flush the vitamins out, leading to a toxic buildup." Meanwhile, even though the "study focuses on diabetics with existing kidney damage, one expert says it contains a valuable message for all people with diabetes." AFP (4/27) also covered the study.
|
 |
| |
|
